Impact of Visceral Manipulation Versus Integrated Neuromuscular Inhibition Technique in Shoulder Impingement Syndrome

Shoulder Impingement Clinical Trial

Official title:

Impact of Visceral Manipulation Versus Integrated Neuromuscular Inhibition Technique in Shoulder Impingement Syndrome

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06271720
• Other study ID #: faculty of physical therapy
• Status: Not yet recruiting
• Phase: N/A
• Start date: March 2024
• Est. completion date: May 2024

Study information

• Verified date: February 2024
• Source: Egyptian Chinese University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will be conducted To evaluate the effect of Visceral Manipulation versus Integrated Neuromuscular Inhibition Technique on the upper fiber of trapezius on pain intensity, pain threshold, shoulder range of motion, and function in shoulder impingement syndrome

Description:

HYPOTHESES

It will be hypothesized that:

1. There will be no statistically significant effect of Visceral Manipulation on the upper fiber of the trapezius on pain intensity, pain threshold, shoulder range of motion, or function in shoulder impingement syndrome

2. There will be no statistically significant effect of the Integrated Neuromuscular Inhibition Technique on the upper fiber of the trapezius on pain intensity, pain threshold, shoulder range of motion, or function in shoulder impingement syndrome.

3. There will be no statistically significant difference in the effect of visceral manipulation versus the integrated neuromuscular inhibition technique on the upper fiber of the trapezius on pain intensity, pain threshold, shoulder range of motion, and function in shoulder impingement syndrome.

This study will be conducted to answer the following questions:

Is there an effect of Visceral Manipulation versus Integrated Neuromuscular Inhibition Technique on the upper fiber of the trapezius on pain intensity, pain threshold, shoulder range of motion, and function in shoulder impingement syndrome?

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 75
• Est. completion date: May 2024
• Est. primary completion date: May 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 40 Years

Eligibility

Inclusion Criteria:

• -active myofascial trigger points in the upper trapezius muscle, and chronic Pain lasting more than 12 weeks

• BMI between 25 and 30 Kg/m².

Exclusion Criteria:

• a previous fracture in the cervical spine or shoulder surgery

• acute inflammatory condition.

• Malignant tumor.

• Multiple osteophytes.

• Cervical posture abnormalities.

• Osteoporosis.

Related Conditions & MeSH terms

• Shoulder Impingement
• Shoulder Impingement Syndrome

Intervention

Other:
• visceral manipulation
visceral manipulation: A palpation technique will be applied till the barrier is felt and it will be applied until release is felt. integrated neuromuscular inhibition: ischemic compression will be applied to trigger point of upper trapezius
• integrated neuromuscular inhibition
It involves applying direct sustained digital pressure to the TrP with sufficient force over dedicated time duration, to slow down the blood supply and relieve the tension within the involved muscle. The pressure is gradually applied, maintained and the gradually released

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Noha Elserty

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	pain intensity	pain intensity will be measured by a visual analog scale, the scale is marked from 0 to 10 while 0 represents no pain and 10 represents intolerable pain	pre treatment and after 4 weeks
Primary	pain pressure threshold	pressure threshold measured by pressure algometer	pre treatment and after 4 weeks
Primary	shoulder range of motion	shoulder flexion and abduction range of motion will be measured by inclinometer	pre treatment and after 4 weeks
Primary	shoulder functional level	The functional level of the shoulder will be measured by shoulder pain and disability index. the index consists of subscales that measure how much shoulder pain interferes with the functional activity of daily living	pre treatment and after 4 weeks